Page last updated: 2024-08-24

oseltamivir and Respiratory Syncytial Virus Infections

oseltamivir has been researched along with Respiratory Syncytial Virus Infections in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's8 (80.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Bont, LJ; Löwensteyn, YN1
Cárdenas, AM; Chang, YC; Feemster, K; Mitchell, SL1
Chung, JW; Jang, KH; Lee, SH; Moon, JD; Park, WJ; Yoo, SJ1
Cummins, A; Millership, S1
Heikkinen, T1
Berger, A; Christopeit, M; Hauf, E; Hentrich, M; Heussel, CP; Kalkreuth, J; Klein, M; Kochanek, M; Lehners, N; Mayer, K; Penack, O; Rieger, C; Schalk, E; Silling, G; Vehreschild, M; von Lilienfeld-Toal, M; Weber, T; Wolf, HH1
Ariza-Heredia, EJ; Chemaly, RF; Shahani, L1
Brydak, LB; Donevski, S; Gawryluk, D; Romanowska, M; Stefanska, I1
Alba, A; Álvarez, AM; Catalán, P; Zubleta, M1
Chi, MH; Goleniewska, K; Higginbotham, JN; Moore, ML; O'Neal, JF; Peebles, RS; Zhou, W1

Reviews

3 review(s) available for oseltamivir and Respiratory Syncytial Virus Infections

ArticleYear
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
    European journal of cancer (Oxford, England : 1990), 2016, Volume: 67

    Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Community-Acquired Infections; Cytosine; Germany; Hand Hygiene; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Influenza, Human; Lung; Masks; Medical Oncology; Metapneumovirus; Neoplasms; Neuraminidase; Nucleic Acid Amplification Techniques; Organophosphonates; Oseltamivir; Paramyxoviridae Infections; Patient Isolation; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Tomography, X-Ray Computed; Virus Diseases

2016
Antiviral therapy for respiratory viral infections in immunocompromised patients.
    Expert review of anti-infective therapy, 2017, Volume: 15, Issue:4

    Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Coronavirus Infections; Cyclopentanes; Guanidines; Humans; Immunocompromised Host; Influenza, Human; Oseltamivir; Palivizumab; Paramyxoviridae Infections; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Zanamivir

2017
[Prophylaxis against respiratory viral disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2012, Volume: 29 Suppl 1

    Topics: Adenoviridae Infections; Adult; Antiviral Agents; Child; Drug Administration Schedule; Humans; Incidence; Influenza, Human; Organ Transplantation; Oseltamivir; Paramyxoviridae Infections; Postoperative Complications; Practice Guidelines as Topic; Respiratory Syncytial Virus Infections; Risk Factors; Stem Cell Transplantation

2012

Other Studies

7 other study(ies) available for oseltamivir and Respiratory Syncytial Virus Infections

ArticleYear
Clinical Development of Respiratory Syncytial Virus Antivirals-What We Can Learn From Oseltamivir.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-31, Volume: 71, Issue:11

    Topics: Antiviral Agents; Double-Blind Method; Hematopoietic Stem Cell Transplantation; Humans; Oseltamivir; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Transplant Recipients

2020
Implementation of a rapid influenza A/B and RSV direct molecular assay improves emergency department oseltamivir use in paediatric patients.
    Journal of medical microbiology, 2018, Volume: 67, Issue:3

    Topics: Antiviral Agents; Child; Child Health; Child, Preschool; Emergency Service, Hospital; Female; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Male; Molecular Diagnostic Techniques; Nasopharynx; Oseltamivir; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sensitivity and Specificity; Treatment Outcome; Virus Diseases

2018
Respiratory Syncytial Virus Outbreak in the Basic Military Training Camp of the Republic of Korea Air Force
    Journal of preventive medicine and public health = Yebang Uihakhoe chi, 2015, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Antiviral Agents; Body Temperature; Disease Outbreaks; Humans; Male; Military Personnel; Multiplex Polymerase Chain Reaction; Oseltamivir; Pharynx; Republic of Korea; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; RNA, Viral; Sputum; Young Adult

2015
Oseltamivir in influenza outbreaks in care homes: challenges and benefits of use in the real world.
    The Journal of hospital infection, 2015, Volume: 90, Issue:4

    Topics: Antiviral Agents; Cost-Benefit Analysis; Databases, Factual; Disease Outbreaks; England; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Nasal Mucosa; Oseltamivir; Paramyxoviridae Infections; Picornaviridae Infections; Polymerase Chain Reaction; Post-Exposure Prophylaxis; Residential Facilities; Respiratory Syncytial Virus Infections; Retrospective Studies; Rhinovirus

2015
Respiratory viruses and children.
    The Journal of infection, 2016, 07-05, Volume: 72 Suppl

    Topics: Antiviral Agents; Bacterial Infections; Child; Child, Preschool; Cost of Illness; Humans; Influenza, Human; Oseltamivir; Otitis Media; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Viral Vaccines; Virus Diseases

2016
Co-infections with influenza and other respiratory viruses.
    Advances in experimental medicine and biology, 2013, Volume: 756

    Topics: Adult; Aged; Alphainfluenzavirus; Antiviral Agents; Child, Preschool; Coinfection; Coronavirus; Coronavirus Infections; Female; Humans; Immunocompromised Host; Influenza, Human; Male; Middle Aged; Oseltamivir; Parainfluenza Virus 3, Human; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections

2013
Cutting Edge: Oseltamivir decreases T cell GM1 expression and inhibits clearance of respiratory syncytial virus: potential role of endogenous sialidase in antiviral immunity.
    Journal of immunology (Baltimore, Md. : 1950), 2007, Mar-01, Volume: 178, Issue:5

    Topics: Animals; Antiviral Agents; CD8-Positive T-Lymphocytes; Down-Regulation; Female; G(M1) Ganglioside; Immunity, Cellular; Lymphocyte Activation; Membrane Microdomains; Mice; Mice, Inbred BALB C; Neuraminidase; Oseltamivir; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Signal Transduction

2007